|
1
|
Wassef M, Blei F, Adams D, Alomari A,
Baselga E, Berenstein A, Burrows P, Frieden IJ, Garzon MC,
Lopez-Gutierrez JC, et al ISSVA Board and Scientific Committee:
Vascular anomalies classification: Recommendations from the
International Society for the study of vascular anomalies.
Pediatrics. 136:e203–e214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Florez-Vargas A, Vargas SO, Debelenko LV,
Perez-Atayde AR, Archibald T, Kozakewich HP and Zurakowski D:
Comparative analysis of D2-40 and LYVE-1 immunostaining in
lymphatic malformations. Lymphology. 41:103–110. 2008.PubMed/NCBI
|
|
3
|
Defnet AM, Bagrodia N, Hernandez SL,
Gwilliam N and Kandel JJ: Pediatric lymphatic malformations:
Evolving understanding and therapeutic options. Pediatr Surg Int.
32:425–433. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mulliken JB, Burrows PE and Fishman SJ:
Mulliken and Young’s vascular anomalies: hemangiomas and
malformations. 2nd edition. Oxford University Press; Oxford; 2013,
View Article : Google Scholar
|
|
5
|
Fonkalsrud EW: Lymphatic disorders.
Pediatric surgery. Grosfeld JL: Mosby/Elsevier; Philadelphia, PA:
pp. 2137–2146. 2006, View Article : Google Scholar
|
|
6
|
Sun ZJ, Zhang L, Zhang WF, Liu B, Li ZB
and Zhao YF: A possible hypoxia-induced endothelial proliferation
in the pathogenesis of epithelioid hemangioma. Med Hypotheses.
67:1133–1135. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
North PE, Waner M, Mizeracki A and Mihm MC
Jr: GLUT1: A newly discovered immunohistochemical marker for
juvenile hemangiomas. Hum Pathol. 31:11–22. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Revencu N, Boon LM, Mendola A, Cordisco
MR, Dubois J, Clapuyt P, Hammer F, Amor DJ, Irvine AD, Baselga E,
et al: RASA1 mutations and associated phenotypes in 68 families
with capillary malformation-arteriovenous malformation. Hum Mutat.
34:1632–1641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liao D and Johnson RS: Hypoxia: A key
regulator of angiogenesis in cancer. Cancer Metastasis Rev.
26:281–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fulda S and Debatin KM: HIF-1-regulated
glucose metabolism: A key to apoptosis resistance? Cell Cycle.
6:790–792. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Simon F, Bockhorn M, Praha C, Baba HA,
Broelsch CE, Frilling A and Weber F: Deregulation of HIF1-alpha and
hypoxia-regulated pathways in hepatocellular carcinoma and
corresponding non-malignant liver tissue - influence of a modulated
host stroma on the prognosis of HCC. Langenbecks Arch Surg.
395:395–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tao J, Li T, Li K, Xiong J, Yang Z, Wu H
and Wang C: Effect of HIF-1alpha on VEGF-C induced
lymphangiogenesis and lymph nodes metastases of pancreatic cancer.
J Huazhong Univ Sci Technolog Med Sci. 26:562–564. 2006. View Article : Google Scholar
|
|
13
|
Katsuta M, Miyashita M, Makino H, Nomura
T, Shinji S, Yamashita K, Tajiri T, Kudo M, Ishiwata T and Naito Z:
Correlation of hypoxia inducible factor-1alpha with lymphatic
metastasis via vascular endothelial growth factor-C in human
esophageal cancer. Exp Mol Pathol. 78:123–130. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Secker GA and Harvey NL: VEGFR signaling
during lymphatic vascular development: From progenitor cells to
functional vessels. Dev Dyn. 244:323–331. 2015. View Article : Google Scholar
|
|
15
|
Tammela T, Saaristo A, Lohela M, Morisada
T, Tornberg J, Norrmén C, Oike Y, Pajusola K, Thurston G, Suda T,
et al: Angiopoietin-1 promotes lymphatic sprouting and hyperplasia.
Blood. 105:4642–4648. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liang X, Yang D, Hu J, Hao X, Gao J and
Mao Z: Hypoxia inducible factor-alpha expression correlates with
vascular endothelial growth factor-C expression and
lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Anticancer Res. 28(3A): 1659–1666. 2008.PubMed/NCBI
|
|
17
|
Mizukami Y, Li J, Zhang X, Zimmer MA,
Iliopoulos O and Chung DC: Hypoxia-inducible factor-1-independent
regulation of vascular endothelial growth factor by hypoxia in
colon cancer. Cancer Res. 64:1765–1772. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boussat S, Eddahibi S, Coste A, Fataccioli
V, Gouge M, Housset B, Adnot S and Maitre B: Expression and
regulation of vascular endothelial growth factor in human pulmonary
epithelial cells. Am J Physiol Lung Cell Mol Physiol.
279:L371–L378. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen W, Weiping S, Cui J, Chen J and Zou
J: Management of cystic lymphangioma in the head and neck region:
Endoscopic cautery and postoperative intratumoral negative
pressure. J Craniofac Surg. 21:1884–1886. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Perkins JA: New frontiers in our
understanding of lymphatic malformations of the head and neck:
Natural history and basic research. Otolaryngol Clin North Am.
51:147–158. 2018. View Article : Google Scholar
|
|
22
|
Ji RC: Hypoxia and lymphangiogenesis in
tumor microenvironment and metastasis. Cancer Lett. 346:6–16. 2014.
View Article : Google Scholar
|
|
23
|
Chen S, Zhang M, Xing L, Wang Y, Xiao Y
and Wu Y: HIF-1α contributes to proliferation and invasiveness of
neuroblastoma cells via SHH signaling. PLoS One. 10:e01211152015.
View Article : Google Scholar
|
|
24
|
Stoeltzing O, McCarty MF, Wey JS, Fan F,
Liu W, Belcheva A, Bucana CD, Semenza GL and Ellis LM: Role of
hypoxia-inducible factor 1alpha in gastric cancer cell growth,
angiogenesis, and vessel maturation. J Natl Cancer Inst.
96:946–956. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nam SY, Ko YS, Jung J, Yoon J, Kim YH,
Choi YJ, Park JW, Chang MS, Kim WH and Lee BL: A hypoxia-dependent
upregulation of hypoxia-inducible factor-1 by nuclear factor-κB
promotes gastric tumour growth and angiogenesis. Br J Cancer.
104:166–174. 2011. View Article : Google Scholar
|
|
26
|
Kimura S, Kitadai Y, Tanaka S, Kuwai T,
Hihara J, Yoshida K, Toge T and Chayama K: Expression of
hypoxia-inducible factor (HIF)-1alpha is associated with vascular
endothelial growth factor expression and tumour angiogenesis in
human oesophageal squamous cell carcinoma. Eur J Cancer.
40:1904–1912. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schoppmann SF, Fenzl A, Schindl M,
Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R and
Birner P: Hypoxia inducible factor-1alpha correlates with VEGF-C
expression and lymphangiogenesis in breast cancer. Breast Cancer
Res Treat. 99:135–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu H and Zhang S: Hypoxia inducible
factor-1α/vascular endothelial growth factor signaling activation
correlates with response to radiotherapy and its inhibition reduces
hypoxia-induced angiogenesis in lung cancer. J Cell Biochem.
119:7707–7718. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morfoisse F, Kuchnio A, Frainay C,
Gomez-Brouchet A, Delisle MB, Marzi S, Helfer AC, Hantelys F, Pujol
F, Guillermet-Guibert J, et al: Hypoxia induces VEGF-C expression
in metastatic tumor cells via a HIF-1α-independent
translation-mediated mechanism. Cell Reports. 6:155–167. 2014.
View Article : Google Scholar
|
|
30
|
Kuwai T, Kitadai Y, Tanaka S, Onogawa S,
Matsutani N, Kaio E, Ito M and Chayama K: Expression of
hypoxia-inducible factor-1alpha is associated with tumor
vascularization in human colorectal carcinoma. Int J Cancer.
105:176–181. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koshikawa N, Iyozumi A, Gassmann M and
Takenaga K: Constitutive upregulation of hypoxia-inducible
factor-1alpha mRNA occurring in highly metastatic lung carcinoma
cells leads to vascular endothelial growth factor overexpression
upon hypoxic exposure. Oncogene. 22:6717–6724. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Simiantonaki N, Jayasinghe C,
Michel-Schmidt R, Peters K, Hermanns MI and Kirkpatrick CJ:
Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma
cell lines. Int J Oncol. 32:585–592. 2008.PubMed/NCBI
|
|
33
|
Okada K, Osaki M, Araki K, Ishiguro K, Ito
H and Ohgi S: Expression of hypoxia-inducible factor (HIF-1alpha),
VEGF-C and VEGF-D in non-invasive and invasive breast ductal
carcinomas. Anticancer Res. 25:3003–3009. 2005.PubMed/NCBI
|
|
34
|
Liu ZY, Qiu HO, Yuan XJ, Ni YY, Sun JJ,
Jing W and Fan YZ: Suppression of lymphangiogenesis in human
lymphatic endothelial cells by simultaneously blocking VEGF-C and
VEGF-D/VEGFR-3 with norcantharidin. Int J Oncol. 41:1762–1772.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Su JL, Yen CJ, Chen PS, Chuang SE, Hong
CC, Kuo IH, Chen HY, Hung MC and Kuo ML: The role of the
VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer. 96:541–545.
2007. View Article : Google Scholar
|
|
36
|
Teng X, Li D and Johns RA: Hypoxia
up-regulates mouse vascular endothelial growth factor D promoter
activity in rat pulmonary microvascular smooth-muscle cells. Chest.
121(Suppl): 82S–83S. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
O TM and Lou MS: Zinc effect on human
lymphatic malformation cells in vitro. Int J Pediatr
Otorhinolaryngol. 80:33–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Boscolo E, Coma S, Luks VL, Greene AK,
Klagsbrun M, Warman ML and Bischoff J: AKT hyper-phosphorylation
associated with PI3K mutations in lymphatic endothelial cells from
a patient with lymphatic malformation. Angiogenesis. 18:151–162.
2015. View Article : Google Scholar :
|
|
39
|
Semenza GL: HIF-1 mediates metabolic
responses to intra-tumoral hypoxia and oncogenic mutations. J Clin
Invest. 123:3664–3671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hong SS, Lee H and Kim KW: HIF-1alpha: A
valid therapeutic target for tumor therapy. Cancer Res Treat.
36:343–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Oliveira SL, Trujillo CA, Negraes PD and
Ulrich H: Effects of ATP and NGF on Proliferation and Migration of
Neural Precursor Cells. Neurochem Res. 40:1849–1857. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen JB, Liu WJ, Che H, Liu J, Sun HY and
Li GR: Adenosine-5′-triphosphate up-regulates proliferation of
human cardiac fibroblasts. Br J Pharmacol. 166:1140–1150. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Song X, Rui C, Meng L, Zhang R, Shen R,
Ding H, Li J, Li J and Long W: Long non-coding RNA RPAIN regulates
the invasion and apoptosis of trophoblast cell lines via complement
protein C1q. Oncotarget. 8:7637–7646. 2017.
|
|
44
|
Xia H, Li Y and Lv X: MicroRNA-107
inhibits tumor growth and metastasis by targeting the BDNF-mediated
PI3K/AKT pathway in human non-small lung cancer. Int J Oncol.
49:1325–1333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xie F, Huang Q, Liu CH, Lin XS, Liu Z, Liu
LL, Huang DW and Zhou HC: MiR-1271 negatively regulates AKT/MTOR
signaling and promotes apoptosis via targeting PDK1 in pancreatic
cancer. Eur Rev Med Pharmacol Sci. 22:678–686. 2018.PubMed/NCBI
|
|
46
|
Wang J, Yang S, Ge W, Wang Y, Han C and Li
M: MiR-613 suppressed the laryngeal squamous cell carcinoma
progression through regulating PDK1. J Cell Biochem. 119:5118–5125.
2018. View Article : Google Scholar
|
|
47
|
Dai J, Wang J, Yang L, Xiao Y and Ruan Q:
miR-125a regulates angiogenesis of gastric cancer by targeting
vascular endothelial growth factor A. Int J Oncol. 47:1801–1810.
2015. View Article : Google Scholar : PubMed/NCBI
|
